search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
58 TESTING


TABLE 2: EUROPEAN PHARMACOPOEIA (EP) PASS CRITERIA FOR TOPICAL PRODUCTS


Log Reduction 2 Day Bacteria Fungi 2 - 7 Day 3 - 14 Day


- 2


28 Day NI NI


needed to be able to offer a vegan alternative for challenge testing, not only to keep up with changing cosmetic trends and also to ensure the entirety of the testing process from start to finish. In October 2022, ISCA partnered up with


The Vegan Society to certify our challenge test methods. We needed to ensure that replacing TSA with VeganSure (VSA), and SDA with Potato Dextrose Agar (PDA) would not affect the standard test methods and that we would get the same performance results.


Preservative efficacy testing (PET) Microbiological assessments, alternately referred to as ‘challenge tests’ or ‘preservative efficacy tests’ (PET), exhibit slight variations depending on the intended global market for the product. The quality of the test method employed varies in accordance with the specific standard procedure being executed. At ISCA, we perform the following preservative efficacy tests: ■ European Pharmacopeia (EP) ■ United States Pharmacopeia (USP) ■ ISO 11930 The European Pharmacopeia (EP) test method is the most stringent method within our testing portfolio. This traditional test method is recognised and accepted globally. Alternatively, our United States Pharmacopeia (USP) and ISO 11930:2019 test methods are recognised standards of ‘Evaluation of the antimicrobial protection of a cosmetic product’. All three test methods employ the same microbiological test species (Table 1).


Testing process Testing was initiated using samples A and B. By conducting both a traditional challenge test (EP) against a Vegan EP method running simultaneously to avoid any other contributing factors interfering with the test. Aseptic techniques were used throughout the entirety of the test procedure to ensure accurate results and eliminate any chance of contamination.


TABLE 4: SAMPLE A RESULTS FROM TRADITIONAL TEST METHOD


Test Species P. aeruginosa S. aureus C.albicans A. brasilliensis


Colony forming units per g after inoculation 2 Day


7 Day <10


8.60 x 101


- -


<10 -<10


- -


14 Day


- -


<10 <10 PERSONAL CARE November 2023 28 Day <10 <10 <10 <10 P. aeruginosa S. aureus C.albicans A. brasilliensis


Pseudomonas aeruginosa Staphylococcus aureus Candia albicans


Aspergillus brasiliensis


NCTC 12924 NCTC 10788 NCPF 3179 NCPF 2275


TABLE 3: INOCULATION COUNTS FOR THE TRADITIONAL EUROPEAN PHARMACOPEIA (EP) AND VEGAN ALTERNATIVE


Test Species Initial Inoculum Level


Traditional Test Method (cfu/g) 8.20 x 105 2.12 x 106 1.96 x 106 3.00 x 105


Initial Inoculum Level Vegan Test Method (cfu/g)


2.34 x 106 2.80 x 106 1.66 x 105 2.50 x 105


Initially, the focus was on ensuring that the


vegan-friendly media, PDA and VSA, could support the growth of our microbial test species, thus facilitating the creation of inoculations to purposely contaminate our sample cosmetic products for testing. All media was prepped and sterilised by autoclaving at 121°C. PDA was employed to cultivate the test


species Candida albicans and Aspergillus brasiliensis, and they were incubated at 25°C for five to seven days. For the bacterial test species, Pseudomonas aeruginosa and Staphylococcus aureus, incubation took place at 35°C for two days. We achieved successful growth of all test species, resulting in inoculation counts ranging from 105


to 106 . Four 20g portions of the samples were transferred to sterile containers and inoculated


TABLE 5: SAMPLE A RESULTS FROM VEGAN ALTERNATIVE TEST METHOD


Test Species


Colony forming units per g after inoculation 2 Day


7 Day <10 <10


- -


<10 -<10


- -


14 Day


- -


<10 <10 28 Day <10 <10 <10 <10


separately with 0.2 ml culture of the test species as detailed below. The inoculated sample portions were mixed using sterile implements to evenly distribute the inoculum and stored at room temperature. The challenge test protocol of the European Pharmacopoeia (EP) 10.0 was followed in exact detail.


Results Inoculation counts tend to exhibit slight variations and are not consistently replicable. This variation is elucidated when comparing the inoculation counts between the traditional test method and the vegan alternative test method (Table 3). All inoculation counts are above the desired threshold for the challenge testing. For both the traditional and vegan alternative test methods, Sample A meets the criteria set


TABLE 6: SAMPLE B RESULTS FROM TRADITIONAL TEST METHOD


Test Species


Colony forming units per g after inoculation 2 Day


7 Day P. aeruginosa 3.0x105 S. aureus C.albicans A. brasilliensis


2.30x 102


- -


3.0x105


1.50x 102


14 Day


- -


- 3.0x105 - 3.0x105


28 Day / / / / www.personalcaremagazine.com


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92